Xponance, Inc. Dexcom Inc Transaction History

Xponance, Inc.

$12.3 Billion
Q3 2025

A detailed history of Xponance, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Xponance, Inc. holds 92,899 shares of DXCM stock, worth $5.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

92,899

Previous 93,993 1.16%

Holding current value

$5.4 Million

Previous $8.2 Million 23.81%

% of portfolio

0.05%

Previous 0.07%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$66.46 - $89.53 $72,707 - $97,945	-1,094 Reduced 1.16%	92,899 $6.25 Million
Q2 2025 Aug 14, 2025	BUY	$59.83 - $87.57 $225,618 - $330,226	3,771 Added 4.18%	93,993 $8.2 Million
Q1 2025 Apr 30, 2025	BUY	$67.74 - $90.75 $69,298 - $92,837	1,023 Added 1.15%	90,222 $6.16 Million
Q4 2024 Feb 10, 2025	SELL	$65.68 - $81.01 $62,264 - $76,797	-948 Reduced 1.05%	89,199 $6.94 Million
Q3 2024 Nov 12, 2024	BUY	$64.0 - $116.06 $43,968 - $79,733	687 Added 0.77%	90,147 $6.04 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $236,173 - $300,703	2,141 Added 2.45%	89,460 $10.1 Million
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $182,066 - $223,319	1,594 Added 1.86%	87,319 $12.1 Million
Q4 2023 Jan 31, 2024	SELL	$75.49 - $124.16 $217,260 - $357,332	-2,878 Reduced 3.25%	85,725 $10.6 Million
Q3 2023 Oct 23, 2023	BUY	$86.06 - $137.93 $146,388 - $234,618	1,701 Added 1.96%	88,603 $8.27 Million
Q2 2023 Jul 13, 2023	BUY	$112.47 - $130.98 $207,169 - $241,265	1,842 Added 2.17%	86,902 $11.2 Million
Q1 2023 Apr 17, 2023	BUY	$104.0 - $122.92 $129,480 - $153,035	1,245 Added 1.49%	85,060 $9.88 Million
Q4 2022 Jan 23, 2023	BUY	$84.98 - $122.67 $457,957 - $661,068	5,389 Added 6.87%	83,815 $0
Q3 2022 Oct 24, 2022	SELL	$76.35 - $94.18 $32,754 - $40,403	-429 Reduced 0.54%	78,426 $6.32 Million
Q2 2022 Aug 02, 2022	BUY	$67.99 - $132.89 $3.99 Million - $7.79 Million	58,640 Added 290.08%	78,855 $5.88 Million
Q1 2022 Apr 20, 2022	BUY	$94.08 - $130.2 $20,133 - $27,862	214 Added 1.07%	20,215 $10.3 Million
Q4 2021 Jan 31, 2022	BUY	$129.87 - $162.82 $680,778 - $853,502	5,242 Added 35.52%	20,001 $10.7 Million
Q3 2021 Nov 05, 2021	SELL	$106.71 - $143.18 $44,498 - $59,706	-417 Reduced 2.75%	14,759 $8.07 Million
Q2 2021 Aug 12, 2021	BUY	$80.99 - $107.93 $119,784 - $159,628	1,479 Added 10.8%	15,176 $6.48 Million
Q1 2021 May 10, 2021	SELL	$84.79 - $104.74 $678 - $837	-8 Reduced 0.06%	13,697 $4.92 Million
Q4 2020 Feb 11, 2021	BUY	$78.0 - $104.5 $19,812 - $26,543	254 Added 1.89%	13,705 $5.07 Million
Q3 2020 Oct 26, 2020	BUY	$95.51 - $112.95 $16,905 - $19,992	177 Added 1.33%	13,451 $5.55 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $832,014 - $1.4 Million	13,274 New	13,274 $5.38 Million

Others Institutions Holding DXCM

# of Institutions

1,082

Shares Held

369M

Call Options Held

5.41M

Put Options Held

5.01M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account